Related Experiment Videos
[Artefacts in porphyria cutanea tarda]
Zeitschrift Fur Hautkrankheiten
|June 1, 1990
Summary
Porphyria cutanea tarda (PCT) patients may experience persistent symptoms despite normal lab values after treatment. Diagnostic artifacts can mimic active PCT, requiring careful clinical evaluation.
Area of Science:
- Dermatology
- Hepatology
- Internal Medicine
Background:
- Porphyria cutanea tarda (PCT) is a common porphyria characterized by skin manifestations due to uroporphyrinogen decarboxylase deficiency.
- Treatment typically involves phlebotomy (blood removal) and/or low-dose hydroxychloroquine to reduce iron overload and porphyrin synthesis.
Observation:
- A 56-year-old patient with PCT showed normalized laboratory values after 19 months of chloroquine and phlebotomy.
- Despite normalized biochemical markers, the patient's clinical symptoms of PCT persisted.
- Further investigation was prompted by the discrepancy between laboratory results and clinical presentation.
Findings:
- Intensive diagnostic exploration revealed the presence of artifacts.
- These artifacts were clinically indistinguishable from active, florid PCT.
- The findings highlight the potential for laboratory or sample-handling artifacts to mimic disease activity.
Implications:
- This case underscores the importance of correlating clinical findings with laboratory results in managing PCT.
- Physicians should consider potential diagnostic artifacts when clinical presentation diverges from expected treatment response.
- Careful evaluation is crucial to avoid misdiagnosis and unnecessary escalation of therapy in PCT patients.